These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 33900176)

  • 21. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak.
    Lauxmann MA; Santucci NE; Autrán-Gómez AM
    Int Braz J Urol; 2020 Jul; 46(suppl.1):6-18. PubMed ID: 32549071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
    Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
    JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial and Ethnic Disparities in Incidence of SARS-CoV-2 Infection, 22 US States and DC, January 1-October 1, 2020.
    Hollis ND; Li W; Van Dyke ME; Njie GJ; Scobie HM; Parker EM; Penman-Aguilar A; Clarke KEN
    Emerg Infect Dis; 2021; 27(5):1477-1481. PubMed ID: 33900192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).
    Park SE
    Clin Exp Pediatr; 2020 Apr; 63(4):119-124. PubMed ID: 32252141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019.
    Amendola A; Bianchi S; Gori M; Colzani D; Canuti M; Borghi E; Raviglione MC; Zuccotti GV; Tanzi E
    Emerg Infect Dis; 2021 Feb; 27(2):648-650. PubMed ID: 33292923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
    Lai CC; Liu YH; Wang CY; Wang YH; Hsueh SC; Yen MY; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):404-412. PubMed ID: 32173241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
    Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
    JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For.
    Carbone M; Lednicky J; Xiao SY; Venditti M; Bucci E
    J Thorac Oncol; 2021 Apr; 16(4):546-571. PubMed ID: 33422679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid Emergence of SARS-CoV-2 in the Greater New York Metropolitan Area: Geolocation, Demographics, Positivity Rates, and Hospitalization for 46 793 Persons Tested by Northwell Health.
    Reichberg SB; Mitra PP; Haghamad A; Ramrattan G; Crawford JM; ; Berry GJ; Davidson KW; Drach A; Duong S; Juretschko S; Maria NI; Yang Y; Ziemba YC
    Clin Infect Dis; 2020 Dec; 71(12):3204-3213. PubMed ID: 32640030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deaths Related to Chagas Disease and COVID-19 Co-Infection, Brazil, March-December 2020.
    Martins-Melo FR; Castro MC; Ribeiro ALP; Heukelbach J; Werneck GL
    Emerg Infect Dis; 2022 Nov; 28(11):2285-2289. PubMed ID: 36170771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serologic Screening of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Cats and Dogs during First Coronavirus Disease Wave, the Netherlands.
    Zhao S; Schuurman N; Li W; Wang C; Smit LAM; Broens EM; Wagenaar JA; van Kuppeveld FJM; Bosch BJ; Egberink H
    Emerg Infect Dis; 2021 May; 27(5):1362-1370. PubMed ID: 33900184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Wei M; Yang N; Wang F; Zhao G; Gao H; Li Y
    Disaster Med Public Health Prep; 2020 Dec; 14(6):796-804. PubMed ID: 32418549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 36. The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United States.
    Sherman AC; Babiker A; Sieben AJ; Pyden A; Steinberg J; Kraft CS; Koelle K; Kanjilal S
    Clin Infect Dis; 2021 Mar; 72(5):e154-e157. PubMed ID: 33161424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.
    Furukawa NW; Brooks JT; Sobel J
    Emerg Infect Dis; 2020 Jul; 26(7):. PubMed ID: 32364890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England.
    Joy M; Hobbs FR; Bernal JL; Sherlock J; Amirthalingam G; McGagh D; Akinyemi O; Byford R; Dabrera G; Dorward J; Ellis J; Ferreira F; Jones N; Oke J; Okusi C; Nicholson BD; Ramsay M; Sheppard JP; Sinnathamby M; Zambon M; Howsam G; Williams J; de Lusignan S
    Br J Gen Pract; 2020 Dec; 70(701):e890-e898. PubMed ID: 33077508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.
    Okba NMA; Müller MA; Li W; Wang C; GeurtsvanKessel CH; Corman VM; Lamers MM; Sikkema RS; de Bruin E; Chandler FD; Yazdanpanah Y; Le Hingrat Q; Descamps D; Houhou-Fidouh N; Reusken CBEM; Bosch BJ; Drosten C; Koopmans MPG; Haagmans BL
    Emerg Infect Dis; 2020 Jul; 26(7):1478-1488. PubMed ID: 32267220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis-Associated Hospitalizations and Deaths after COVID-19 Shelter-In-Place, San Francisco, California, USA.
    Louie JK; Agraz-Lara R; Romo L; Crespin F; Chen L; Graves S
    Emerg Infect Dis; 2021 Aug; 27(8):2227-2229. PubMed ID: 34287142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.